JAGSNPHARM

—

· NSE

✦

Analyst Note

4d ago

Jagsonpal Pharmaceuticals is currently overvalued, with a margin of safety of -68.2%, indicating that its current price of ₹current price is 34.9% above its 52-week low. The company has shown a strong earnings growth of 23.8% in the last year, driven by a return on equity of 16.7%. Sentiment has turned bearish over the last week despite a bullish 30-day trend. This stock is suitable for conservative investors seeking stable returns.

0 articles

No company news found yet.

Valuation not yet computed for JAGSNPHARM. Trigger it via POST /valuation/run/JAGSNPHARM

Price vs Market

JAGSNPHARM

Nifty 50

Shareholding Pattern

Sentiment Trend — Last 30 Days

Historical Returns

Financial History

Annual P&L data not available yet.

Institutional Activity

Bulk deals, block deals, short selling & delivery volume — NSE data

Insider Trading

Community Pulse

What is Dalal Street saying?

r/IndiaInvestments · r/Dalal_Street_Investments · r/IndianStockMarket

No Reddit mentions found yet for JAGSNPHARM.

StockTwits

What traders are saying right now

StockTwits

No StockTwits activity found for JAGSNPHARM.

Search Interest

Google Trends · India · Last 90 days

Trends

Trend data not yet available — check back soon.

Telegram Channels

ET Markets · CNBC TV18 · Moneycontrol · Zee Business · NDTV Profit

No Telegram mentions found yet for JAGSNPHARM.

Exchange Filings

BSE announcements · last 90 days

NSE ↗BSE ↗

Loading filings…

Share this Stock

Download card · Share on WhatsApp

Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant